ATRX and neuroblastoma: They highlight histone variants as key components of ALT-deregulated ATRX protein interactions and indicate that activity of the PRC2 complex could be reduced due to attenuated EED expression resulting from 11q loss, providing additional evidence for histone-dependent chromatin deregulation by copy-number dosage in ALT neuroblastomas.